N-メチル-D-グルカミン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H315：皮膚刺激

  H319：強い眼刺激

  H335：呼吸器への刺激のおそれ

• 注意書き

  P261：粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。

  P304+P340：吸入した場合：空気の新鮮な場所に移し、呼吸しやすい 姿勢で休息させること。

  P305+P351+P338：眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

  P405：施錠して保管すること。

N-メチル-D-グルカミン 価格

MSDS Information

• Meglumine

N-メチル-D-グルカミン 化学特性,用途語,生産方法

• 外観

  白色～ほとんど白色, 結晶性粉末～粉末又は塊

• 定義

  本品は、次の化学式で表される有機化合物である。

• 溶解性

  水に易溶、メタノール, エタノールに難溶、クロロホルム, エーテルに不溶。

• 用途

  イオン交換、キレート樹脂原料。有機合成原料。

• 化粧品の成分用途

  pH調整剤

• 効能

  診断補助薬 (放射線不透過性造影剤)

• 化学的特性

  Meglumine occurs as a white to slightly yellow-colored crystalline powder; it is odorless or with a slight odor.

• 使用

  N-Methyl-D-glucamine is used in conjunction with iodinated organic compounds in contrast media viz. diatrizoate meglumine and iodipamide meglumine. It is useful in ion-exchange resins to chelate boron ions selectively. It is also used as an excipient in pharmaceuticals, in cosmetics and X-ray contrast media. It is also employed in the synthesis of surface active agents, pharmaceuticals and dyes.

• 調製方法

  Meglumine is prepared by the imination of glucose and monomethylamine, in an alcoholic solution, followed by catalytic hydrogenation.

• 定義

  ChEBI: A hexosamine that is D-glucitol in which the hydroxy group at position 1 is substituted by the nitrogen of a methylamino group. A crystalline base, it is used in preparing salts of certain acids for use as diagnostic radiopaque media, whi e its antimonate is used as an antiprotozoal in the treatment of leishmaniasis.

• 一般的な説明

  Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
  Meglumine is a glucose-derived secondary amine which is widely used as an excipient in pharmaceutical formulations.

• 応用例（製薬）

  Meglumine is an organic base used as a pH-adjusting agent and solubilizing agent, primarily in the preparation of soluble salts of iodinated organic acids used as X-ray contrast media.

• 安全性

  Meglumine is widely used in parenteral pharmaceutical formulations and is generally regarded as a nontoxic material at the levels usually employed as an excipient.
  LD₅₀ (mouse, IP): 1.68 g/kg

• 貯蔵

  Meglumine does not polymerize or dehydrate unless heated above 150°C for prolonged periods.
  The bulk material should be stored in a well-closed container in a cool, dry place. Meglumine should not be stored in aluminum containers since it reacts to evolve hydrogen gas; it discolors if stored in containers made from copper or copper alloys. Stainless steel containers are recommended.

• 純化方法

  Crystallise N-methyl-D(-)-glucamine from MeOH. Its solubility in H2O is 10%. [Karrer & Herkenrath Helv Chim Acta 20 83 1957 also for other N-alkyl derivatives, Beilstein 4 IV 1914.]

• 不和合性

  Incompatible with aluminum, copper, mineral acids, and oxidizing materials. Differential scanning calorimetry studies suggest meglumine is incompatible with glipizide.

• 規制状況(Regulatory Status)

  Included in the FDA Inactive Ingredients Database (injections; oral tablets). Included in parenteral medicines licensed in the UK.

N-メチル-D-グルカミン 上流と下流の製品情報

N-メチル-D-グルカミン 生産企業

Global(693)Suppliers

N-メチル-D-グルカミン スペクトルデータ(IR1、IR2、MS、Raman)

6284-40-8, N-メチル-D-グルカミン キーワード